INTRACTABLE ASTHMA IN 72 YEAR LADY

Case Report: Nocturnal Exacerbation of Intractable Asthma

Introduction

Intractable asthma in elderly patients poses significant management challenges due to comorbidities, polypharmacy, and heightened susceptibility to infections. This case highlights a 72-year-old woman with poorly controlled asthma exacerbated by bronchitis and sinusitis, complicated by a transient nocturnal respiratory event despite aggressive therapy.

Case Presentation

Demographics

  • Age/Gender: 72-year-old female.
  • Medical History: Asthma, hypertension, lobectomy (past).
  • Medications: Losartan 50 mg/day (hypertension).

Presentation

The patient presented with an asthma exacerbation unresponsive to:

  • Ventolin inhaler (2 puffs BID),
  • Pulmocort (budesonide 2 puffs BID),
  • Ipratropium + Ventolin nebulizer every 12 hours.

Initial Workup

  • BP: 135/80 mmHg (on losartan).
  • Labs: Elevated urea (7.5 mmol/L), leucocytosis (12.3 × 10³/μL), neutrophilia, elevated rheumatoid factor.
  • Imaging: Normal chest X-ray (prior to admission).

Diagnosis

Intractable asthma secondary to bronchitis and sinusitis.

Treatment Initiated

  • Bronchodilators: Ventolin increased to 2 puffs QID, added Symbicort (budesonide/formoterol) 2 puffs BID.
  • Antibiotics: Cefuroxime 500 mg BID (for bacterial bronchitis/sinusitis).
  • Anti-inflammatory: Prednisolone 40 mg BID.
  • Adjuncts: Montelukast 10 mg daily.

Nocturnal Event

On day 3, she developed sudden-onset dyspnea lasting 5 hours overnight, resolving spontaneously by morning.

Investigations

  • Echocardiogram (2 weeks prior): Normal ejection fraction, right atrial pressures, and valve function.
  • Pulse Oximetry: 98% (no hypoxemia).
  • Repeat Labs: Persistent leucocytosis (12.3 × 10³/μL) and neutrophilia.

Differential Diagnosis for Nocturnal Event

  • Asthma Exacerbation: Nocturnal worsening of airway inflammation/bronchospasm.
  • Infection-Related: Mucus plugging from unresolved bronchitis/sinusitis.
  • Dehydration/Secretions: Elevated urea (7.5 mmol/L) indicating dehydration → thickened airway secretions.
  • Environmental Triggers: Allergen/irritant exposure (e.g., dust mites, cold air).

Management Adjustments

  • Increased oral fluid intake to reduce mucus viscosity.
  • Sputum culture/sensitivity ordered; cefuroxime continued pending results.
  • Added tiotropium (LAMA) for nocturnal bronchospasm.
  • Serial peak expiratory flow (PEF) measurements.

Outcome

  • Symptoms resolved after 5 hours; no recurrence with adjusted therapy.
  • Follow-up sputum culture confirmed bacterial infection (sensitive to cefuroxime).
  • Discharged on tapered prednisolone, continued symbicort, montelukast, and tiotropium.

Discussion

This case underscores the complexity of managing intractable asthma in older adults. Key insights:

  • Nocturnal asthma exacerbations are linked to circadian variations in airway inflammation.
  • Infections (e.g., bronchitis/sinusitis) perpetuate mucus production and airway obstruction.
  • Dehydration is a modifiable risk factor for mucus plugging.
  • Multimodal therapy (anti-inflammatory, bronchodilators, hydration) is critical in refractory cases.

Final Diagnosis

Nocturnal asthma exacerbation secondary to bronchitis, sinusitis, and dehydration-induced mucus plugging.

Author

DR ABUNYEWA, M.D M.B ChB MSc MIS MACDA MACPM MACP, Preventive Health Institute

Date: 14th March 2025

Disclaimer & Credit: All medical articles including ours, are informative and provide population trends not specific to individuals which can be very different. Always seek personalized medical advice from your doctor for individual healthcare decisions.

Posted March 14, 2025